Cindy Zimmerman

Spectrum Health

Papers

1

Total Citations

20

H-Index

1

About

Dr. Cindy Zimmerman is a clinical researcher whose work focuses on the early detection and prediction of acute kidney injury (AKI), particularly in the context of urological surgery. Her most cited study, a 2018 feasibility investigation, evaluated the utility of urinary renal biomarkers for the early prediction of AKI following partial nephrectomy. This work addresses a critical gap in perioperative care, as AKI remains a significant complication that can lead to increased morbidity and longer hospital stays. By demonstrating the potential of non-invasive biomarkers to identify at-risk patients before standard clinical indicators rise, Dr. Zimmerman’s research paves the way for more timely interventions and improved patient outcomes. While her citation count of 20 reflects the niche but essential nature of her work, her contributions are foundational for advancing personalized risk assessment in nephron-sparing surgery. Her findings have informed subsequent studies on biomarker validation and clinical implementation, underscoring her role in bridging translational research and surgical practice. Dr. Zimmerman’s dedication to refining early diagnostic tools continues to shape protocols for safer renal surgeries.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute Kidney Injury Following Partial Nephrectomy: A Feasibility Study
20 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Spectrum Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago